AMICUS THERAPEUTICS, INC. (36) | Note Agreements (4)
- Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on May 22, 2019)
- Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on March 13, 2019)
- Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on February 8, 2019)
- Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on January 24, 2019)